{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:41:24Z","timestamp":1784925684115,"version":"3.55.0"},"reference-count":48,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"unspecified","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","award":["(ref: 12\/205\/28)"],"award-info":[{"award-number":["(ref: 12\/205\/28)"]}],"id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Herpes simplex virus (HSV) encephalitis is a rare severe form of brain inflammation that commonly leaves survivors and their families with devastating long-term consequences. The virus particularly targets the temporal lobe of the brain causing debilitating problems in memory, especially verbal memory. It is postulated that immunomodulation with the corticosteroid, dexamethasone, could improve outcomes by reducing brain swelling. However, there are concerns (so far not observed) that such immunosuppression might facilitate increased viral replication with resultant worsening of disease. A previous trail closed early because of slow recruitment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>DexEnceph is a pragmatic multicentre, randomised, controlled, open-label, observer-blind trial to determine whether adults with HSV encephalitis who receive dexamethasone alongside standard antiviral treatment with aciclovir for have improved clinical outcomes compared with those who receive standard treatment alone. Overall, 90 patients with HSV encephalitis are being recruited from a target of 45 recruiting sites; patients are randomised 1:1 to the dexamethasone or control arms of the study. The primary outcome measured is verbal memory as assessed by the Weschler Memory Scale fourth edition Auditory Memory Index at 26 weeks after randomisation. Secondary outcomes are measured up to 72 weeks include additional neuropsychological, clinical and functional outcomes as well as comparison of neuroimaging findings. Patient safety monitoring occurs throughout and includes the detection of HSV DNA in cerebrospinal fluid 2 weeks after randomisation, which is indicative of ongoing viral replication. Innovative methods are being used to ensure recrutiment targets are met for this rare disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>DexEnceph aims to be the first completed randomised controlled trial of corticosteroid therapy in HSV encephalitis. The results will provide evidence for future practice in managing adults with the condition and has the potential to improve outcomes .<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial has ethical approval from the UK National Research Ethics Committee (Liverpool Central, REF: 15\/NW\/0545, 10 August 2015). Protocol V.2.1, July 2019. The results will be published and presented as soon as possible on completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"ISRCTN11774734\">ISRCTN11774734<\/jats:ext-link>\n                      , EUDRACT 2015-001609-16.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-041808","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T10:50:19Z","timestamp":1626951019000},"page":"e041808","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Protocol for DexEnceph: a randomised controlled trial of dexamethasone therapy in adults with herpes simplex virus encephalitis"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4016-2712","authenticated-orcid":false,"given":"Thomas","family":"Whitfield","sequence":"first","affiliation":[{"name":"Department of Clinical Infection, Medical Microbiology and Immunology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Clinical Infection, Medical Microbiology and Immunology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Davies","sequence":"additional","affiliation":[{"name":"Clinical Trials Research Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylviane","family":"Defres","sequence":"additional","affiliation":[{"name":"Department of Clinical Infection, Medical Microbiology and Immunology, University of Liverpool, Liverpool, UK"},{"name":"PLEASE REMOVE THIS ADDRESS ENTRY, X, X, X"},{"name":"Tropical and Infectious Diseases Unit, Liverpool University Hospitals Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Department of Clinical Infection, Medical Microbiology and Immunology, University of Liverpool, Liverpool, UK"},{"name":"Neurology Department, Alder Hey Children\"s NHS Foundation Trust, Liverpool, Merseyside, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Hooper","sequence":"additional","affiliation":[{"name":"Department of Clinical Infection, Medical Microbiology and Immunology, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tangney","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girvan","family":"Burnside","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rosala- Hallas","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry","family":"Moore","sequence":"additional","affiliation":[{"name":"Deptment of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Das","sequence":"additional","affiliation":[{"name":"Neuroradiology Department, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"South London Specialist Virology Centre, King\"s College Hospital NHS Foundation Trust, London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Parkes","sequence":"additional","affiliation":[{"name":"Division of Neuroscience & Experimental Psychology, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Keller","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Liverpool University Hospitals NHS Foundation Trust, Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Roberts","sequence":"additional","affiliation":[{"name":"The Queen\"s Medical Research Institute, The University of Edinburgh, Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Easton","sequence":"additional","affiliation":[{"name":"The Encephalitis Society, Malton, North Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Touati","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, CHU Grenoble Alpes, Grenoble, Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kneen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alder Hey Children\u2019s NHS Foundation Trust, Liverpool, UK"},{"name":"REMOVE THI ADDRESS, XXXXX, XXX, XXX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Stahl","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University of Grenoble, Grenoble, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool, Liverpool, UK"},{"name":"National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection Ecology and Veterinary Sciences, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"2025121512321569000_11.7.e041808.1","doi-asserted-by":"publisher","DOI":"10.3201\/eid0902.020218"},{"key":"2025121512321569000_11.7.e041808.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2006.04.002"},{"key":"2025121512321569000_11.7.e041808.3","doi-asserted-by":"publisher","DOI":"10.1086\/648419"},{"key":"2025121512321569000_11.7.e041808.4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1909.130064"},{"key":"2025121512321569000_11.7.e041808.5","doi-asserted-by":"crossref","unstructured":"Solomon T , Hart IJ , Beeching NJ , et al . Viral encephalitis\u202f: a clinician \u2019 s guide 2007:288\u2013305.","DOI":"10.1136\/jnnp.2007.129098"},{"key":"2025121512321569000_11.7.e041808.6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1474-4422(16)00059-4","article-title":"Encephalitis: raising awareness and collaborating in research","volume":"15","author":"Easton","year":"2016","journal-title":"Lancet Neurol"},{"key":"2025121512321569000_11.7.e041808.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.3.321"},{"key":"2025121512321569000_11.7.e041808.8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1046-y"},{"key":"2025121512321569000_11.7.e041808.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70222-X"},{"key":"2025121512321569000_11.7.e041808.10","doi-asserted-by":"publisher","DOI":"10.1086\/341405"},{"key":"2025121512321569000_11.7.e041808.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3630"},{"key":"2025121512321569000_11.7.e041808.12","first-page":"180","article-title":"The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors","volume":"10","author":"Utley","year":"1997","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"2025121512321569000_11.7.e041808.13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00415-014-7604-4","article-title":"Identifying neural correlates of memory and language disturbances in herpes simplex encephalitis: a voxel-based morphometry (VBM) study","volume":"262","author":"Frisch","year":"2015","journal-title":"J Neurol"},{"key":"2025121512321569000_11.7.e041808.14","doi-asserted-by":"publisher","DOI":"10.1080\/09602010701202238"},{"key":"2025121512321569000_11.7.e041808.15","first-page":"478","article-title":"Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies","volume":"1996","author":"Hokkanen","year":"1994","journal-title":"Neurosurgery, and Psychiatry"},{"key":"2025121512321569000_11.7.e041808.16","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2552-1"},{"key":"2025121512321569000_11.7.e041808.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162755"},{"key":"2025121512321569000_11.7.e041808.18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.678"},{"key":"2025121512321569000_11.7.e041808.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0941-6"},{"key":"2025121512321569000_11.7.e041808.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146288","article-title":"Characteristic cytokine and chemokine profiles in encephalitis of infectious, immune-mediated, and unknown aetiology","volume":"11","author":"Michael","year":"2016","journal-title":"PLoS One"},{"key":"2025121512321569000_11.7.e041808.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1597-2"},{"key":"2025121512321569000_11.7.e041808.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(98)00061-6"},{"key":"2025121512321569000_11.7.e041808.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2009.01.004"},{"key":"2025121512321569000_11.7.e041808.24","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.1445"},{"key":"2025121512321569000_11.7.e041808.25","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.11.1334"},{"key":"2025121512321569000_11.7.e041808.26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/WNL.0000000000002132","article-title":"Relapse in herpes simplex virus encephalitis","volume":"85","author":"Bale","year":"2015","journal-title":"Neurology"},{"key":"2025121512321569000_11.7.e041808.27","doi-asserted-by":"publisher","DOI":"10.1080\/13550280390173373"},{"key":"2025121512321569000_11.7.e041808.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2004.10.054"},{"key":"2025121512321569000_11.7.e041808.29","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(01)02469-7"},{"key":"2025121512321569000_11.7.e041808.30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(71)91019-1","article-title":"Dexamethasone treatment in herpes-simplex encephalitis","volume":"297","author":"Upton","year":"1971","journal-title":"Lancet"},{"key":"2025121512321569000_11.7.e041808.31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(72)90505-3","article-title":"Dexamethasone in herpes-simplex encephalitis","volume":"299","author":"Habel","year":"1972","journal-title":"The Lancet"},{"key":"2025121512321569000_11.7.e041808.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179159"},{"key":"2025121512321569000_11.7.e041808.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021334"},{"key":"2025121512321569000_11.7.e041808.34","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.049676"},{"key":"2025121512321569000_11.7.e041808.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.05.007"},{"key":"2025121512321569000_11.7.e041808.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2016.05.002"},{"key":"2025121512321569000_11.7.e041808.37","doi-asserted-by":"publisher","DOI":"10.1159\/000073864"},{"key":"2025121512321569000_11.7.e041808.38","doi-asserted-by":"publisher","DOI":"10.1159\/000350572"},{"key":"2025121512321569000_11.7.e041808.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2010.10.014"},{"key":"2025121512321569000_11.7.e041808.40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-8-40"},{"key":"2025121512321569000_11.7.e041808.41","first-page":"200","article-title":"Research and Reporting Methods Annals of Internal Medicine SPIRIT 2013 Statement\u202f: Defining Standard Protocol Items for Clinical Trials","volume":"1","author":"Hro","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025121512321569000_11.7.e041808.42","unstructured":"The medicines for human use (clinical trials) regulations, 2004. Available: http:\/\/www.legislation.gov.uk\/uksi\/2004\/1031\/schedule\/1\/made [Accessed 19 Jun 2019]."},{"key":"2025121512321569000_11.7.e041808.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601163140303"},{"key":"2025121512321569000_11.7.e041808.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92623-0"},{"key":"2025121512321569000_11.7.e041808.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3916"},{"key":"2025121512321569000_11.7.e041808.46","unstructured":"Spc. dexamethasone SPC 2014:1\u20134."},{"key":"2025121512321569000_11.7.e041808.47","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1212\/01.wnl.0000450946.75616.32","article-title":"Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report","volume":"82","author":"Gilbert","year":"2014","journal-title":"Neurology"},{"key":"2025121512321569000_11.7.e041808.48","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a9f531"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-041808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:32:25Z","timestamp":1765830745000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-041808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,22]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjopen-2020-041808"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-041808","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}